Vera Therapeutics, Inc. VERA

US Biotechnology

$30.25 ▼ -1.18% ($-0.36)

🔥 High Short Interest

Open $30.45

Prev Close $30.61

Day Range $29.80 – $31.08

52W Range $23.86 – $56.05

Market Cap $2.23B

Beta 1.23

EPS (TTM) $-5.86

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2021-05-14
Shares Out.	72,060,000
Website	veratx.com/ ↗
Phone	13026587581
Employees	362
Revenue	$0
Gross Profit	$0
Net Income	-$109.7M
Free Cash Flow	-$338.9M
Total Assets	$533.0M
Total Liabilities	$125.2M
Equity	$407.8M

About Vera Therapeutics, Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Vera Therapeutics, Inc. is a publicly traded company under the ticker symbol VERA on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.